Dual ?V?6/?V?1 integrin inhibitor bexotegrast reduces fibrogenesis in pathological cell populations present in the fibrotic human lung

From the transcriptome landscape to innovative preclinical models in lung diseases

Chair(s): Sara Cuevas Ocana, Arnaud Mailleux

Session type: Oral presentation

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Development of a bronchial epithelium with a sensory innervation both derived from induced pluripotent stem cells

Arnaud Bourdin

Replay

Poster

Abstract

Slides

Late Breaking Abstract - Volatile organic compounds in exhaled breath reflect physiological changes in ultramarathon runners

Agnieszka Smolinska

Replay

Poster

Abstract

Slides

Identification of abnormal airway niches in the fibrotic lung using Spatial Transcriptomics

Aurelien Justet

Replay

Abstract

Slides

Single-cell RNA sequencing of bronchoalveolar lavage reveals pro-inflammatory macrophage activation in fibrotic hypersensitivity pneumonitis

Avraham Unterman

Replay

Poster

Abstract

Slides

Transcriptomic landscape of post-covid-19 pulmonary fibrosis (PCPF): insights and implications of bronchoalveolar lavage (BAL)

Mohammad Shadab Ali

Replay

Poster

Abstract

Slides

LSC - 2023 - In vitro modelling of respiratory infections in Idiopathic Pulmonary Fibrosis using patient-specific hiPSC-derived alveolar epithelial cells

Serna Valverde Ana Lilia

Replay

Abstract

Slides

Preclinical evaluation of HL001, a novel lysophosphatidic acid 1 (LPA1) receptor antagonist, for idiopathic pulmonary fibrosis utilizing physiologically relevant stem cell-derived lung organoids

Yuki Yamamoto

Replay

Abstract

Slides

Dual ?V?6/?V?1 integrin inhibitor bexotegrast reduces fibrogenesis in pathological cell populations present in the fibrotic human lung

Replay

Poster

Abstract

Slides

Involvement of the CXCR4/CXCL12 axis in skeletal muscle wasting in a murine model of Chronic Obstructive Pulmonary Disease (COPD)

Pauline Henrot

Replay

Poster

Abstract

Slides

Discussion and Q&A

Replay

The ERS International Congress 2023, Milan

#{title}